In vitro activity of azthreonam, a monobactam antibiotic.
We studied the activity of azthreonam (SQ 26,776), a novel monocyclic beta-lactam compound, against a variety of clinical isolates. It was more potent than moxalactam, cefoperazone, cefamandole, cefoxitin, ticarcillin, tobramycin, or amikacin against strains of Klebsiella spp., Serratia spp., and th...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1982
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185668/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6891198/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.5.832 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|